Tobira takes on three execs
This article was originally published in Scrip
Executive Summary
Tobira Therapeutics has completed its senior management team with three hires. Joining the company are Caroline Loewy as executive vice president and chief financial officer, Dr Jeff Enejosa as senior director of clinical research, and Mark Menning as director of pharmaceutical sciences. Ms Loewy's prior positions include CFO of two publicly-held biotechnology companies and a Wall Street equity research analyst. Dr Enejosa was director, clinical research at Gilead Sciences. Mr Menning most recently served as senior research scientist, formulation and process development, at Gilead Sciences.